{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:07:11Z","timestamp":1772752031255,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.09.025","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T08:36:38Z","timestamp":1222331798000},"page":"6053-6063","source":"Crossref","is-referenced-by-count":38,"title":["Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)"],"prefix":"10.1016","volume":"26","author":[{"given":"Marta","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannelie","family":"Korf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Adnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Jurion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Garzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.09.025_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri1666","article-title":"Immune responses to tuberculosis in developing countries: implications for new vaccines","volume":"5","author":"Rook","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.09.025_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.09.025_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.09.025_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib6","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2008.09.025_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.micinf.2005.04.002","article-title":"Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins","volume":"7","author":"Horwitz","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2008.09.025_bib8","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1128\/IAI.00531-06","article-title":"Protection elicited by two glutamine auxotrophs of Mycobacterium tuberculosis and in vivo growth phenotypes of the four unique glutamine synthetase mutants in a murine model","volume":"74","author":"Lee","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib9","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.025_bib10","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"69","author":"Olsen","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib11","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.micinf.2005.03.010","article-title":"Plasmid DNA vaccination","volume":"7","author":"Huygen","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2008.09.025_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib14","first-page":"23","article-title":"Prime-boost immunization strategies for infectious diseases","volume":"4","author":"McShane","year":"2002","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2008.09.025_bib15","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib16","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.67.6.2941-2950.1999","article-title":"Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family","volume":"67","author":"Dillon","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib17","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.165.12.7140","article-title":"T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection","volume":"165","author":"Skeiky","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(99)00536-0","article-title":"Learning from the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"452","author":"Cole","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2008.09.025_bib19","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/IAI.72.4.2170-2176.2004","article-title":"Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-Kilodalton culture filtrate protein and ESAT-6","volume":"72","author":"Demangel","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tube.2005.02.002","article-title":"Expression, immunochemical characterization and localization of the Mycobacterium tuberculosis protein p27","volume":"85","author":"Le Moigne","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2008.09.025_bib21","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1128\/IAI.71.11.6116-6123.2003","article-title":"PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family","volume":"71","author":"Okkels","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1054\/tube.2001.0304","article-title":"Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c","volume":"81","author":"Sampson","year":"2001","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2008.09.025_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/423938","article-title":"Regions of high antigenicity within the hypothetical PPE major polymorphic tandem repeat open-reading frame, Rv2608, show a differential humoral response and a low T cell response in various categories of patients with tuberculosis","volume":"190","author":"Chakhaiyar","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.025_bib24","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1128\/IAI.71.11.6338-6343.2003","article-title":"PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell response","volume":"71","author":"Choudhary","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib25","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1128\/IAI.73.8.5004-5014.2005","article-title":"Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis","volume":"73","author":"Singh","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/bbrc.1999.0591","article-title":"Search for genes potentially involved in Mycobacterium tuberculosis virulence by mRNA differential display","volume":"258","author":"Rindi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1574-695X.2007.00315.x","article-title":"Variation of the expression of Mycobacterium tuberculosis ppe44 gene among clinical isolates","volume":"51","author":"Rindi","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib28","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/IAI.72.11.6471-6479.2004","article-title":"Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG Prime-Rv3407 DNA boost vaccination against tuberculosis","volume":"72","author":"Mollenkopf","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1099\/jmm.0.45960-0","article-title":"Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice","volume":"54","author":"Bonanni","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib30","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1128\/IAI.60.7.2880-2886.1992","article-title":"Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice","volume":"60","author":"Huygen","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"75","author":"Roupie","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon {gamma} and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.09.025_bib33","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"Snewin","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib34","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/IAI.70.7.3681-3688.2002","article-title":"Improved tuberculosis DNA vaccines by formulation in cationic lipids","volume":"70","author":"D\u2019Souza","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1074-7613(00)80340-4","article-title":"Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology","volume":"6","author":"Aichele","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2008.09.025_bib36","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.4049\/jimmunol.172.11.6913","article-title":"Induction of in vivo functional Db restricted cytolytic T cell activity against a putative phosphate transport receptor of M. tuberculosis","volume":"172","author":"Romano","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/349720a0","article-title":"Identifying antigenic T-cell sites","volume":"349","author":"Feller","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.025_bib39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1128\/IAI.66.4.1527-1533.1998","article-title":"Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection","volume":"66","author":"Denis","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib40","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib41","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/IAI.72.4.2420-2424.2004","article-title":"Effect of growth state on transcription levels of genes encoding major secreted antigens of Mycobacterium tuberculosis in the mouse lung","volume":"72","author":"Shi","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib42","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/IAI.00335-07","article-title":"DNA polymorphisms in the pepA and PPE18 genes among clinical strains of Mycobacterium tuberculosis: implications for vaccine efficacy","volume":"75","author":"Hebert","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.025_bib43","first-page":"736","article-title":"European concerted action on new generation genetic markers and techniques for the epidemiology and control of tuberculosis. Beijing\/W genotype Mycobacterium tuberculosis and drug resistance","volume":"12","author":"Anonymous","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.025_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2249.2006.03162.x","article-title":"The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Gu\u00e9rin (BCG) vaccines: is there a link?","volume":"145","author":"Abebe","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2008.09.025_bib45","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1016\/j.vaccine.2005.03.003","article-title":"Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41","volume":"23","author":"Skeiky","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.025_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2148-6-95","article-title":"Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions","volume":"6","author":"Gey van Pittius","year":"2006","journal-title":"BMC Evol. Biol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T02:22:11Z","timestamp":1684549331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":46,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08012486"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}